Cancer Survivorship Care Needs Routine Mental Health Screening, Not Just Physical Follow-Up

Finishing cancer treatment does not necessarily mean the end of the psychological impact of cancer. For many survivors, the period after active treatment can bring a different set of challenges: fear that the cancer will return, uncertainty about surveillance scans, sleep problems, changes in identity and persistent anxiety or depression.

Updated clinical recommendations are placing greater emphasis on routine Mental Health screening in cancer survivorship care, rather than waiting for patients to spontaneously report psychological symptoms.

Approximately one in three cancer survivors experiences clinically significant anxiety, depression or psychological distress. Yet distress can remain hidden during routine oncology appointments, particularly when patients are focused on physical recovery or believe that emotional difficulties are simply something they are expected to endure.

The emerging approach is therefore broader than asking whether a patient “feels depressed”. It involves structured screening, assessment of trauma-related symptoms and suicide risk, recognition of fear of cancer recurrence and access to evidence-based psychological treatment when needed.

Why psychological problems can intensify after cancer treatment

The end of active treatment can be psychologically complicated.

During chemotherapy, radiotherapy, surgery or other intensive treatment, patients often have frequent contact with healthcare professionals. Appointments, treatment schedules and immediate medical priorities provide a clear structure.

Once treatment ends, that structure can suddenly disappear.

Instead of receiving regular treatment, survivors may transition into surveillance appointments that are separated by weeks or months. For some people, this creates a new form of uncertainty: What happens if the cancer comes back?

This fear can become particularly intense before follow-up scans, blood tests or specialist appointments. A minor physical symptom may also trigger worries that the cancer has returned.

Consequently, survivorship is not simply a period of recovery. For some patients, it is a psychological transition from active treatment to long-term uncertainty.

How common is psychological distress among cancer survivors?

Approximately one in three cancer survivors experiences clinically significant depression, anxiety or broader psychological distress following active treatment.

That figure demonstrates why mental health screening should not be restricted to patients who visibly appear distressed.

Some survivors may continue working, attend appointments and maintain normal conversations while privately experiencing intrusive thoughts, insomnia, panic symptoms or persistent fear of recurrence.

This creates a problem with relying entirely on clinical impressions. A patient who appears calm in a 15-minute consultation may still be struggling significantly outside the clinic.

Validated screening tools can help clinicians identify symptoms that might otherwise remain hidden.

Why asking patients directly is not enough

Informal questions such as “How are you coping?” can be useful, but they may not identify clinically important symptoms on their own.

Patients may minimise psychological distress because they do not want to appear ungrateful after successful treatment. Others may assume that anxiety is an unavoidable consequence of having had cancer.

Some may also focus on physical symptoms and never mention emotional changes unless specifically asked.

Structured screening provides a more consistent approach. It can create an opportunity for clinicians to identify symptoms early and determine whether additional assessment is appropriate.

The goal is not to diagnose every survivor with a psychiatric disorder. Instead, screening can help distinguish normal emotional reactions from persistent or severe symptoms that require intervention.

When should cancer survivors be screened?

Mental health assessment should ideally be incorporated throughout survivorship rather than performed only once.

Particular attention may be warranted during transitions in cancer care, including the move from active treatment to surveillance.

Screening can also become especially relevant when a patient’s physical concerns increase, when surveillance results are pending or when there are noticeable changes in sleep, mood, behaviour or daily functioning.

A longitudinal approach is important because psychological distress can change over time. A survivor who coped well immediately after treatment may develop significant anxiety months or years later.

Fear of cancer recurrence deserves specific attention

One of the most distinctive psychological challenges of survivorship is fear of cancer recurrence.

This is different from general anxiety because it is directly connected to the possibility that cancer could return.

For some survivors, the fear may remain manageable. For others, it can become intrusive and interfere with sleep, relationships, work or willingness to plan for the future.

Routine surveillance can paradoxically become a source of anxiety. A scan intended to provide reassurance may generate weeks of anticipation and worry.

This is why survivorship care should not treat every psychological symptom as generic anxiety. Understanding the specific source of distress can help clinicians choose a more appropriate intervention.

Trauma symptoms can also be missed

Cancer treatment can be psychologically traumatic, particularly when patients experience life-threatening illness, prolonged hospitalisation, intensive procedures or repeated exposure to frightening medical information.

Post-traumatic stress symptoms may include intrusive memories, avoidance, heightened alertness and distress associated with reminders of the cancer experience.

Updated screening approaches lower the threshold for identifying possible post-traumatic stress symptoms using the Primary Care PTSD Screen for DSM-5.

The revised approach considers two affirmative responses as sufficient to warrant further assessment, with avoidance behaviour receiving particular attention.

The practical implication is important: clinicians should not wait until trauma symptoms become overwhelming before considering a more detailed psychological evaluation.

Why lower screening thresholds can matter

A screening tool is not a diagnosis. Its purpose is to identify people who may need further assessment.

Lowering the threshold for a positive screen can therefore increase the chance of identifying patients who might otherwise be missed.

The trade-off is that more patients may require follow-up assessment after an initial positive result.

In survivorship care, that may be worthwhile because the consequences of untreated psychological distress can extend beyond emotional wellbeing. Severe anxiety or depression can affect sleep, physical activity, social functioning and engagement with healthcare.

The most appropriate approach is therefore a two-step process: screen broadly, then assess carefully.

Suicide risk requires a different level of urgency

Depression and anxiety can generally be managed through planned clinical pathways, but suicidal thoughts require immediate attention.

Cancer survivors have been reported to face a suicide risk approximately two to four times higher than that of the general population, making systematic safety assessment particularly important when severe psychological symptoms are identified.

A safety assessment should consider more than whether a patient says they are depressed.

Clinicians should evaluate factors such as pain, sleep disruption, substance use, recent losses and access to potentially lethal means. Social circumstances and protective factors are also relevant.

Strong family relationships, employment, social support and a sense of responsibility can provide important protective factors, although they should never be assumed to eliminate suicide risk.

What happens when suicide risk is identified?

A patient considered to be at immediate risk requires urgent clinical intervention rather than routine follow-up.

Depending on the circumstances, management can include emergency psychiatric assessment, development of an immediate safety plan, involvement of appropriate support networks and reduction of access to lethal means.

The key principle is that suicide risk should be treated as a clinical safety issue, not simply another survivorship symptom.

Exercise can be part of psychological cancer care

Psychological treatment does not necessarily begin with medication.

Regular physical activity can play an important role in survivorship care and can help reduce symptoms of anxiety and depression.

Exercise may also address several problems simultaneously. Physical activity can support cardiovascular health, improve sleep, maintain physical function and help survivors regain a sense of control over their bodies after treatment.

For mild to moderate psychological distress, evidence suggests that structured physical activity can have meaningful effects comparable to standard antidepressant approaches in some settings.

Exercise should nevertheless be individualised. A survivor’s cancer history, treatment effects, physical limitations and overall health need to be considered before recommending a particular activity level.

Cognitive behavioural therapy can target fear and insomnia

Cognitive behavioural therapy (CBT) is one of the most established psychological interventions relevant to cancer survivorship.

CBT can help patients identify patterns of thinking that amplify anxiety and develop practical strategies for responding to distress.

It can be particularly useful for problems such as fear of cancer recurrence, insomnia and trauma-related symptoms.

For example, a survivor who interprets every headache as evidence of cancer recurrence may develop escalating anxiety that makes it difficult to sleep or concentrate. CBT can help the patient examine these thought patterns without dismissing the underlying concern.

The objective is not to tell patients that their fears are irrational. Instead, therapy can help them develop healthier ways of responding to uncertainty.

Medication requires special attention in cancer survivors

Antidepressant medication may be appropriate for some survivors with clinically significant depression or anxiety, particularly when symptoms are persistent or severe.

However, medication choices should take the patient’s cancer treatment into account.

One particularly important example involves survivors taking tamoxifen for hormone receptor-positive breast cancer.

Tamoxifen requires metabolic conversion to active compounds, and some antidepressants can interfere with the enzymes involved in this process. Strong CYP2D6 inhibitors may therefore be problematic in patients receiving tamoxifen.

This illustrates why survivorship mental health treatment should remain connected to oncology care. A medication that might be reasonable for depression in the general population may require additional consideration in someone receiving cancer therapy.

The case for integrated psycho-oncology care

The most effective survivorship model is unlikely to separate physical and psychological health completely.

Cancer survivors may simultaneously deal with fatigue, pain, sleep disturbance, hormonal changes, cardiovascular risk, fear of recurrence and depression. These problems can interact with one another.

For example, persistent pain can interfere with sleep. Poor sleep can worsen anxiety and concentration. Anxiety can then make physical symptoms feel more threatening.

An integrated model allows clinicians to consider these connections rather than treating each symptom in isolation.

A practical framework for survivorship mental health screening

The overlooked problem: survivorship care can create a false sense of recovery

One of the most important insights from the updated approach is that successful cancer treatment and psychological recovery are not necessarily simultaneous events.

A patient may receive reassuring medical results while continuing to experience substantial fear, grief or trauma symptoms.

In fact, the reduction in medical appointments after active treatment may make psychological problems harder to detect. During intensive therapy, distress is visible within a highly structured healthcare environment. During surveillance, the patient may spend much more time outside that system.

This creates a potential gap in care.

Routine mental health screening can help close that gap by making psychological wellbeing a standard part of survivorship rather than an optional extra offered only after a patient reaches crisis point.

What cancer survivors should know

Experiencing anxiety, sadness, sleep problems or fear after cancer treatment does not mean that a survivor has failed to “move on”. These reactions can occur even after successful treatment.

What matters is the persistence and impact of the symptoms.

If distress interferes with sleep, work, relationships, physical activity, medical appointments or everyday life, discussing it with an oncology team or mental health professional can be appropriate.

Patients should also understand that psychological support is not limited to medication. Psychotherapy, exercise, sleep interventions, social support and specialised psycho-oncology services can all form part of survivorship care.

Why the future of cancer care must include mental health

Cancer survival is improving, which means more people are living for years or decades after their initial diagnosis.

As the survivor population grows, healthcare systems will need to move beyond a narrow definition of successful cancer care based only on tumour control.

A patient who is medically cancer-free but experiencing severe anxiety, depression or trauma-related symptoms still needs meaningful healthcare support.

The future of survivorship care is therefore likely to involve a more holistic model in which physical surveillance and psychological monitoring continue alongside one another.

Conclusion

Routine mental health screening should be considered a core component of modern cancer survivorship care. Approximately one in three cancer survivors experiences clinically significant psychological distress, yet many symptoms may remain hidden during routine oncology appointments.

Earlier screening can help identify anxiety, depression, fear of recurrence and trauma-related symptoms before they become more disabling. Lower screening thresholds may improve detection of post-traumatic stress, while systematic safety evaluations are essential when severe mood symptoms or suicide risk are present.

Management should be individualised and may include physical activity, evidence-based psychotherapy such as cognitive behavioural therapy and carefully selected medication. For patients receiving treatments such as tamoxifen, potential drug interactions must also be considered.

The larger lesson is straightforward: surviving cancer is not the same as being finished with cancer’s psychological consequences. By making mental health screening routine and longitudinal, oncology services can move closer to a survivorship model that treats the whole patient rather than focusing exclusively on whether the cancer has returned.